Ποια είναι η τιμή για CardieX Limited (CDX)

Η τιμή για CardieX Limited (CDX) είναι $0.01754999

Ποια είναι η κεφαλαιοποίηση αγοράς για CardieX Limited (CDX)

Η κεφαλαιοποίηση αγοράς για CardieX Limited (CDX) είναι $2.52M

CardieX Limited (CDX) Τιμή και Κεφαλαιοποίηση Αγοράς

CardieX Limited, established in Sydney, Australia, in 1994, is a global innovator specializing in the design, production, and distribution of medical devices for cardiovascular health management. Operating across the Americas, Europe, and the Asia Pacific, the company collaborates with pharmaceutical firms by providing its advanced SphygmoCor XCEL devices. It also delivers comprehensive laboratory and data management services, ensuring high-quality datasets for clinical trial sponsors. Under its CONNEQT brand, CardieX develops cutting-edge home vascular health solutions, which encompass remote patient monitoring, tools for decentralized clinical trials, specialized wearables, and medical applications. A flagship product is the CONNEQT Pulse device, a home-based system that leverages proprietary SphygmoCor technology to precisely measure central blood pressure, arterial waveforms, and other vital arterial health parameters. CardieX serves a diverse clientele, including hospitals, clinics, research institutions, and pharmaceutical companies. The company also maintains a strategic alliance with LifeQ, Inc., focusing on wearable device technology. CardieX Limited was formerly known as AtCor Medical Holdings Limited until its name change in June 2018.

Η τιμή για CDX	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$37,953.11 $2.52M	NVDA	$5.452T	+216,257,005.08%
$31,257.22 $2.52M	AAPL	$4.490T	+178,103,773.94%
$28,976.54 $2.52M	GOOG	$4.162T	+165,108,471.23%
$25,592.81 $2.52M	MSFT	$3.676T	+145,827,937.67%
$19,722.19 $2.52M	AMZN	$2.833T	+112,377,093.79%

Η τιμή για CDX

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$37,953.11 $2.52M